Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LUXIR+
- Development stage
- Unknown
- Lead developer
- Kimera Labs
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Topical
01
Overview
LUXIR+ is a high-concentration, topical exosome-based biologic developed by Kimera Labs for cosmetic skin rejuvenation and repair. It contains approximately 15 trillion mesenchymal stem cell (MSC)-derived exosomes per 1mL vial, sourced from a single pre-COVID human placental donor. These exosomes are suspended in 0.9% normal saline and carry a complex cargo of proteins, enzymes, and growth factors designed to facilitate tissue repair and anti-aging effects. LUXIR+ is an enhanced version of the standard Luxir product, offering three times the concentration of microvesicles. It is typically applied topically following advanced skincare procedures such as microneedling or laser treatments to accelerate healing and address deep wrinkles and damaged skin.
- Brand names
- LUXIR+
- Other names
- Luxir+LUXIR+-Kimera Exosomes
Beyond the preview
Go deeper on LUXIR+.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LUXIR+.